ASH Poster Walks
Moderator:
Disclosures:
No relevant conflicts of interest to declare.
Panelists:
Deepika S. Darbari, MD, Children's National Medical Center
,
Sherif M. Badawy, MD, Ann & Robert Lurie Children's Hospital
,
Patrick T. McGann, MD, Children's Hospital Medical Center
,
Jane A. Little, MD, Cwru/University Hospitals
,
Laura M De Castro, MD, MHSc, University of Pittsburgh Medical Center
,
Victor R. Gordeuk, MD, University of Illinois at Chicago
,
Theodosia A. Kalfa, MD, PhD, Cincinnati Children's Hospital Medical Center
,
Celeste K. Kanne, BA, Baylor College of Medicine
,
Seung Yup Lee, Georgia Institute of Technology and Emory University
,
Yagahira E. Castro-Sesquen, Ph.D., Howard University
,
Susanna A Curtis, MD, MS, Montefiore Health Systems
and
Alexandra Boye-Doe, Case Western Reserve University School of Medicine
Disclosures:
No relevant conflicts of interest to declare.
The following abstracts will be featured in this session:
Ex-Vivo FT-4202 Treatment Improves Hemoglobin Oxygen Affinity and Membrane Health in Red Blood Cells of Patients with Hemoglobin SS and Hemoglobin SC Disease Irrespective of Prior Hydroxyurea Use, Theodosia Kalfa
Red Cell Rheology Biomarkers to Assess Cure in Gene-Based Therapies, Celeste Kanne
Assessment of Cerebral Blood Flow and Oxygen Extraction in Pediatric Sickle Cell Disease with Non-Invasive Diffuse Optical Spectroscopies, Seung Yup Lee
Use of Multiple Urinary Biomarkers for Early Detection of Chronic Kidney Disease in Sickle Cell Anemia Patients, Yagahira Castro-Sesquen
Real World Clinical Experience with Oxbryta Therapy in Individuals with Sickle Cell Disease, Susanna Curtis
The Grndad Registry: Contemporary Natural History Data and an Analysis of Real-World Patterns of Use and Limitations of Disease Modifying Therapy in Adults with SCD, Alexandra Boye-Doe